Gentel® Biosciences has announced that it has obtained an exclusive license to novel technology for manufacturing highly-reproducible nitrocellulose protein microarray slides. The technology, ...
ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray ...
The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...
The MarketWatch News Department was not involved in the creation of this content. -- Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via "patch" technology and utilizes ...
Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via "patch” technology and utilizes Micron's first-in-class dissolvable microarray technology Research builds on Emory's ...
HAYWARD, CA--(Marketwired - March 24, 2016) - Biolog, Inc. announced today that it has received another patent on its Phenotype MicroArray™ (PM) technology, extending the breadth and depth of its ...
Recently published data generated by researchers at The University of Queensland and Vaxxas shows effective delivery of a nucleic acid-based COVID-19 vaccine in a preclinical animal study utilizing ...
"[People] had been developing Arabidopsis microarrays for a number of years, and these were some of the first papers that published high-quality data with real biological conclusions," says Chris Town ...
Sommige resultaten zijn verborgen omdat ze mogelijk niet toegankelijk zijn voor u.
Niet-toegankelijke resultaten weergeven
Feedback